Summary of Significant Accounting Policies (Details 3) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||||
Current Segment assets | ||||||||||||||
Cash | $ 7,966,500 | $ 7,966,500 | $ 7,827,487 | $ 1,283,523 | ||||||||||
Prepaid expenses and other current assets | 723,921 | 723,921 | 944,683 | 1,477,197 | ||||||||||
Total current segment assets | 8,703,348 | 8,703,348 | 8,790,782 | 2,765,680 | ||||||||||
Long-term segment assets | ||||||||||||||
Property and equipment, net | 621,903 | 621,903 | 672,861 | 571,873 | ||||||||||
Right of use assets, net | 347,298 | 347,298 | 432,397 | 575,227 | ||||||||||
Total segment assets | 10,396,547 | 10,396,547 | 10,615,312 | 4,462,365 | ||||||||||
Revenues | 7,475 | $ 7,870 | 8,415 | $ 23,798 | 34,890 | 17,065 | ||||||||
Segment Operating expenses | ||||||||||||||
Research and development expense | 163,096 | 7,280 | 165,296 | 18,120 | 29,125 | 145,182 | ||||||||
Sales and marketing expense | 182,446 | 158,514 | ||||||||||||
Amortization expense | 19,738 | 19,182 | ||||||||||||
Interest expense, net | 4,690 | 5,817 | 9,381 | 11,634 | 18,640 | 6,735,013 | ||||||||
Total Segment Net Income (Loss) | (1,683,199) | (1,287,995) | (3,318,263) | (5,451,579) | (8,383,453) | $ (8,376,834) | ||||||||
Reportable segments [Member] | ||||||||||||||
Current Segment assets | ||||||||||||||
Cash | 7,966,500 | 7,966,500 | 7,827,487 | |||||||||||
Accounts receivable | 12,927 | 12,927 | 18,612 | |||||||||||
Prepaid expenses and other current assets | 723,921 | 723,921 | 944,683 | |||||||||||
Total current segment assets | 8,703,348 | 8,703,348 | 8,790,782 | |||||||||||
Long-term segment assets | ||||||||||||||
Property and equipment, net | 621,903 | 621,903 | 672,861 | |||||||||||
Right of use assets, net | 347,298 | 347,298 | 432,397 | |||||||||||
Intangible assets, net | 5,333 | |||||||||||||
Deposits | 12,850 | 12,850 | 12,850 | |||||||||||
Patent costs, net | 711,148 | 711,148 | 701,089 | |||||||||||
Total segment assets | 10,396,547 | 10,396,547 | $ 10,615,312 | |||||||||||
Revenues | 7,475 | 7,870 | 8,415 | 23,798 | ||||||||||
Segment Operating expenses | ||||||||||||||
Payroll and related costs | 360,471 | 451,245 | 961,517 | 3,387,020 | ||||||||||
Rent and facility expense | 89,461 | 59,667 | 155,854 | 101,222 | ||||||||||
Legal and professional expense | 209,744 | 94,736 | 511,264 | 444,473 | ||||||||||
Consulting and contractor expense | 165,905 | 173,499 | 326,707 | 396,277 | ||||||||||
Insurance expense | 158,263 | 181,821 | 314,830 | 363,558 | ||||||||||
Filing fees expense | 22,159 | 1,804 | 42,290 | 76,957 | ||||||||||
Transfer agent expense | 5,554 | 6,587 | 11,936 | 20,153 | ||||||||||
Software and web computing expense | 101,723 | 65,275 | 180,314 | 137,488 | ||||||||||
Board compensation expense | 49,778 | 49,958 | 99,390 | 99,958 | ||||||||||
Investor relations expense | 3,750 | 6,429 | 7,500 | 67,524 | ||||||||||
Other segment items | 136,742 | [1] | 129,456 | [1] | 233,990 | [2] | 249,788 | [2] | ||||||
Research and development expense | 163,096 | 7,280 | 165,296 | 18,120 | ||||||||||
Sales and marketing expense | 211,043 | 57,779 | 252,863 | 92,181 | ||||||||||
Amortization expense | 8,485 | 4,794 | 53,923 | 9,587 | ||||||||||
Interest expense, net | 4,500 | 5,535 | 9,004 | 11,071 | ||||||||||
Total Segment Net Income (Loss) | (1,683,199) | (1,287,995) | (3,318,263) | (5,451,579) | ||||||||||
Reportable segments [Member] | Product Test Sales [Member] | ||||||||||||||
Long-term segment assets | ||||||||||||||
Revenues | $ 7,475 | $ 7,870 | $ 8,415 | $ 23,798 | ||||||||||
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The current portion of nonphysical assets, excluding financial assets, if these assets are classified into the current and noncurrent portions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of lessee's right to use underlying asset under operating lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|